Mammography Equipment Market Size, Share, and Growth Forecast 2026 - 2033

Mammography Equipment Market by Type (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), Application (Breast Tomosynthesis, CAD), and Regional Analysis, 2026 - 2033

ID: PMRREP3578
Calendar

November 2026

192 Pages

Author : Abhijeet Surwase

Mammography Equipment Market Size and Trend Analysis

The global mammography equipment market size is likely to be valued at US$ 3.80 billion in 2026 and is projected to reach US$ 5.45 billion by 2033, growing at a CAGR of 5.3% during forecast period between 2026 and 2033.

Expanding national screening mandates, rapid clinical adoption of digital breast tomosynthesis, and the integration of artificial intelligence into radiological workflows. The World Health Organization (WHO) has identified early breast cancer detection as a cornerstone of its Global Breast Cancer Initiative, launched in 2021, providing institutional momentum that continues to convert policy commitment into capital procurement across both high-income and emerging-market health systems.

Key Industry Highlights

  • Dominant Region: North America is forecast to dominate the regional market command 39% of market revenue in 2026, fueled by mature screening infrastructure and CMS reimbursement support for tomosynthesis. The 2024 USPSTF guideline lowering the recommended screening age to 40 is projected to sustain elevated capital procurement spending well into the late 2020s, making the region the most reliable near-term revenue base for equipment vendors.
  • Fastest growing Region: Asia Pacific is expanding at a CAGR of 7.2% outpacing every other regional market as government-mandated breast cancer screening programs scale across China, India, and Southeast Asia. China's Healthy China 2030 initiative is a primary catalyst, directing public health spending toward imaging infrastructure in lower-tier urban centres where screening penetration remains critically low.
  • Dominant Product Type: Digital system hold 43% of market share in 2026 by type, a share sustained by the near-universal adoption of PACS-integrated workflows across accredited breast imaging facilities.
  • graphy's compatibility with AI-assisted detection platforms is reinforcing its installed-base durability and complicating the value proposition of legacy analogue systems.
  • Fastest-growing Product Type: 3D Systems is likely to be the fastest-growing type segment, propelled by clinical evidence that digital breast tomosynthesis reduces recall rates by approximately 15-40% compared with 2D mammography, per data from the Norwegian Breast Cancer Screening Program. AI-tomosynthesis pairing is becoming a procurement standard at high-volume screening centers, extending beyond academic hospitals into community imaging networks.

See exactly what you're buying — Before you spend a dollar.

Get a free sample copy of our market report: data, tables, charts, research depth, analyst insights, and relevance of our research - all in hand before you commit.

DRO Analysis

Driver - AI-Assisted Detection Driving Rapid Technology Refresh

Radiologist workflow pressures and documented improvements in sensitivity are accelerating the integration of computer-aided detection and AI-based triage tools into mammography workflows. Hologic, Inc. commercially launched its Genius AI Detection platform, which pairs directly with its Selenia Dimensions 3D mammography system, reducing false-negative rates in multi-reader clinical trials.

Healthcare providers are increasingly requiring AI compatibility as a procurement specification, effectively triggering capital equipment replacement cycles even at institutions with relatively recent flat-panel detector systems. This dynamic compresses the typical equipment replacement timeline from ten years to six or seven, raising annual unit demand across North America and Western Europe.

Restraint - Specialist Radiologist Shortages in Emerging Markets

Advanced digital mammography platforms require trained radiologists and mammography technologists to generate clinical value. Per International Agency for Research on Cancer (IARC) assessments, many low- and middle-income countries face severe shortages of breast imaging specialists, rendering capital equipment underutilized even when it is procured. This structural workforce gap slows both initial equipment adoption and justification for technology refresh, creating a friction point that limits the mammography equipment sector's addressable market outside established health systems.

Opportunity - Portable and Mobile Mammography Systems for Rural and Community Deployment

Population-level screening coverage remains critically incomplete in rural geographies across North America, Europe, and Asia Pacific. Mobile mammography units truck-mounted or van-based systems integrating compact flat-panel detectors and satellite-linked image transmission are attracting meaningful public health investment. FUJIFILM Corporation has expanded its portfolio of portable digital mammography solutions designed for mobile deployment contexts.

The U.S. Department of Health and Human Services has funded community health center screening initiatives that specify mobile-compatible equipment, creating a distinct procurement channel separate from hospital capital budgets. This market segment rewards manufacturers who can miniaturize without compromising spatial resolution a technically demanding specification that narrows effective competition.

Category-wise Analysis

Why Do Digital Systems Command Such a Dominant Share of the Mammography Equipment Market?

Digital systems are projected to lead the segment hold nearly 43% of market share in 2026, a position earned through decisive clinical and operational superiority over legacy film-screen technology. Full-field digital mammography platforms deliver superior contrast resolution at lower mean glandular dose, which is critical when imaging dense breast tissue, the dominant concern driving radiologist preference in population screening programs.

Hospital radiology networks and accredited breast imaging centers routinely specify digital platforms because they integrate directly with Picture Archiving and Communication Systems (PACS) and teleradiology infrastructure, enabling remote reading and multi-site workflow management that analogue systems cannot support.

3D systems are likely to be the fastest-growing segment within the mammography equipment landscape. Digital breast tomosynthesis produces layered cross-sectional images that reduce tissue overlap the primary cause of false positives in conventional 2D mammography. Siemens Healthineers received FDA 510(k) clearance for its MAMMOMAT Revelation tomosynthesis platform in a regulatory pathway that has accelerated category adoption, with the American College of Radiology (ACR) now endorsing tomosynthesis as a preferred modality for dense-breast populations.

Application Insights

Breast tomosynthesis is expected to lead and the fastest growing segment, account for 52% of market share in 2026, driven by its demonstrated superiority in cancer detection rate per thousand screens compared with 2D-only acquisition. Breast cancer screening programs at large academic medical centers including Mayo Clinic and Memorial Sloan Kettering Cancer Center have standardized on tomosynthesis-based acquisition protocols, reflecting clinical evidence published across multiple large-scale European and North American trial programs.

Payers who have established distinct reimbursement pathways for the modality, particularly CMS in the U.S., provide financial predictability that sustains institutional procurement. Hologic's Genius 3D Mammography platform the most widely deployed tomosynthesis system globally continues capturing replacement installations as older 2D flat-panel units age out of service, reinforcing both volume growth and average selling price stability through the forecast period.

Not every business fits the same mold. Your research shouldn't either.

Connect with the team for a customization and get a one-of-a-kind report scoped to your niche — The insights your competitors won't have access to.

Regional Insights

North America Mammography Equipment Market Trends and Insights

North America is forecast to lead the regional market capture around 39% of mammography equipment market revenue in 2026. The region's dominance reflects mature screening infrastructure, favorable CMS reimbursement for tomosynthesis procedures, and the highest installed base of full-field digital mammography systems globally. AI-driven detection software adoption is accelerating technology refresh at a rate faster than the standard equipment replacement cycle, sustaining capital spending momentum through the forecast horizon.

U.S. Mammography Equipment Market Size

The U.S. is projected to hold around 88% of the North American regional market in 2026. The 2024 USPSTF screening age reduction to 40 years is the single most consequential near-term demand catalyst, expanding the screened population and placing immediate volume and capacity pressure on existing imaging center networks. Facility expansion and equipment upgrade spending will likely accelerate through 2027-2028 as health systems respond to this policy shift.

Canada Mammography Equipment Market Size

Canada is expected to account around 12% of the North American regional market in 2026. Provincial health authorities particularly Ontario Health and BC Cancer are progressively integrating tomosynthesis into organized screening programs, creating incremental procurement demand beyond routine replacement. Federal investment in rural health access is expected to support mobile mammography fleet expansion through the late 2020s.

Europe Mammography Equipment Market Trends and Insights

Europe is estimated to command about 19% of market share in 2026. The European Commission's Europe's Beating Cancer Plan, adopted in 2021, commits member states to achieving 90% breast cancer screening coverage by 2025, directly driving procurement upgrades across national programs in Germany, France, Italy, and the Nordic states. Regulatory compliance with the European Union Medical Device Regulation (EU MDR 2017/745) is raising the technical and clinical documentation threshold for new entrants, reinforcing incumbent vendor positions.

Germany Mammography Equipment Market Size

Germany is projected to account for 24% of the European regional market in 2026. Germany operates one of Europe's most systematically organized national breast screening programs, administered through Kooperationsgemeinschaft Mammographie, which mandates digital equipment standards and regular quality audits across all screening units. Program expansion and periodic equipment accreditation cycles provide reliable, recurring procurement demand through the forecast period.

U.K. Mammography Equipment Market Size

The U.K. is anticipated to command nearly 20% of the European regional market in 2026. NHS England's structured national breast screening program, which invites women aged 50 to 70 for triennial screening, maintains a large installed base of digital mammography units subject to periodic capital refresh. The NHS Long Term Plan's commitment to earlier cancer diagnosis is expected to support tomosynthesis adoption and potential screening age reduction, sustaining procurement activity through 2030.

What Is Driving Asia Pacific's Position as the Fastest-Growing Region in the Mammography Equipment Market?

Asia Pacific is likely to be the fastest growing during the forecast period between 2026 to 2033. Rising breast cancer incidence rates, expanding middle-class healthcare utilization, and significant government investment in cancer detection infrastructure are collectively driving this acceleration. China and Japan together represent the dominant installed-base markets, while India is emerging as a high-growth procurement environment as national cancer screening policy matures.

China Mammography Equipment Market Size

China is expected to hold nearly 35% of the Asia Pacific regional market in 2026. The National Health Commission of China has prioritized breast cancer screening under its Healthy China 2030 initiative, expanding subsidized screening access in tier-2 and tier-3 cities. Domestic manufacturers including Mindray Medical International Limited are actively developing cost-optimized digital mammography platforms targeting public hospital procurement, introducing competitive pricing pressure on multinational vendors.

Japan Mammography Equipment Market Size

Japan is anticipated to capture about 24% of the Asia Pacific regional market in 2026. Japan maintains one of Asia's most structured population screening frameworks, with municipal-level breast screening administered under the Health Promotion Act, sustaining consistent equipment procurement and service contracts. Adoption of AI-assisted reading tools to address radiologist capacity constraints positions Japan as an early adopter market for next-generation mammography workflow solutions through 2033.

Competitive Landscape

The global mammography equipment market operates as a moderately concentrated oligopoly. Hologic, Inc. and FUJIFILM Corporation collectively hold the largest global installed-base positions, competing primarily on image quality, AI software integration, and service contract comprehensiveness. Koninklijke Philips N.V., Siemens Healthineers (a subsidiary of Siemens AG), and CANON MEDICAL SYSTEMS CORPORATION contest the mid-to-premium tier, differentiating on PACS interoperability and dose optimization.

General Electric HealthCare maintains a strong presence across hospital radiology departments through bundled imaging capital contracts. Smaller specialists Metaltronica S.p.A., IMS Giotto S.p.A., and Planmeca Oy occupy defined niches in European and specialty-clinic procurement. Competitive advantage turns on three variables: regulatory clearance speed across major markets, the depth of proprietary AI detection capabilities, and the breadth of service and training networks in emerging markets.

Key Industry Developments

  • In June 2026, FUJIFILM India installed its AI-powered AMULET SOPHINITY digital mammography system at NM Medical in Khar, Mumbai, marking the first installation of this next-generation platform in India. The installation aimed to strengthen preventive healthcare infrastructure and support early breast cancer detection through advanced breast imaging technology. The AMULET SOPHINITY system combined artificial intelligence (AI), high-definition imaging and patient-centric design to improve diagnostic precision, screening comfort and workflow efficiency. It featured a 50-micron direct conversion detector with a hexagonal pixel structure that supported high-resolution imaging and low-dose screening.
  • In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc., a global provider of AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc., to accelerate the development, commercialization and adoption of advanced AI-powered mammography tools. The collaboration aimed to strengthen breast imaging capabilities by integrating artificial intelligence into mammography workflows and supporting improvements in breast cancer detection and diagnostic efficiency.

Companies Covered in Mammography Equipment Market

  • FUJIFILM Corporation
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Siemens
  • CANON MEDICAL SYSTEMS CORPORATION
  • Metaltronica S.p.A.
  • IMS Giotto S.p.A.
  • General Electric
  • Planmeca Oy
  • Mindray Medical International Limited
Frequently Asked Questions

The global mammography equipment market is valued at US$ 3.80 billion in 2026.

The 2024 USPSTF guideline expanding recommended screening to women aged 40 and above, which significantly enlarges the eligible population in the U.S., and the WHO Global Breast Cancer Initiative's policy advocacy accelerating screening program investment in lower-income countries.

Digital systems hold the largest share of the mammography equipment market at 43% in 2026, driven by their seamless integration with hospital PACS infrastructure, superior image quality for dense-breast populations, and compatibility with AI-assisted detection platforms.

North America leads the global mammography equipment market with 39% revenue share in 2026, supported by two structural advantages: a mature network of accredited breast imaging centers and comprehensive CMS reimbursement pathways for both 2D and tomosynthesis mammography procedures.

Equipment vendors with cloud-integrated CAD platforms a capability validated by Google Health's peer-reviewed AI mammography research are best positioned to convert emerging-market public health procurement budgets into scalable, long-term equipment and software contracts.

Some leading players include Hologic, Inc., FUJIFILM Corporation, Siemens Healthineers, Koninklijke Philips N.V., and General Electric HealthCare, competing primarily on AI software integration depth, image resolution, and service network breadth.

UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

6th Floor, Teerth Technospace, Teerth Realties, Office No. B- 604, Baner, Pune, Maharashtra 411045

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -
Mammography Equipment Market Size, Share & Forecast 2033